论文部分内容阅读
化学治疗是治疗恶性肿瘤主要方法之一,阿霉素(ADM)是目前使用最广泛的化疗药物,而由阿霉素所引起的心脏毒性屡见不鲜,笔者自1996年5月～1998年3月,应用杭州正大青春宝药业有限公司生产的参麦注射液治疗阿霉素所致的心脏毒性,有一定的疗效。现归纳总结如下: 1 材料与方法 1.1 病例选择 住院患者,均经病理学或细胞学检查确诊为恶性肿瘤;在治疗前患者心、肝、肾功能皆正常,Karnofsky评分≥60分,预计生存时间在3个月以上。 1.2 一般资料 全组118例患者,根据住院先后随机分为两组。 1.2.1 参麦组 60例中,男性41例,女性19例;年龄28岁～74岁,中位年龄56岁。具体病种为肺
Chemotherapy is one of the main methods for the treatment of malignant tumors. Adriamycin (ADM) is currently the most widely used chemotherapeutic drug, and cardiotoxicity caused by doxorubicin is not uncommon. The author has been from May 1996 to March 1998. The application of Shenmai Qingbao Pharmaceutical Co., Ltd. of Hangzhou Zhengmai injection for treatment of doxorubicin-induced cardiac toxicity, have a certain effect. The summary can be summarized as follows: 1 Materials and methods 1.1 Case selection Hospitalized patients were diagnosed as malignant tumors by pathological or cytological examination; before treatment, patients’ heart, liver and kidney functions were normal, Karnofsky score was ≥ 60 points, and the estimated survival time In 3 months or more. 1.2 General Information The entire group of 118 patients was randomly divided into two groups according to the hospitalization. 1.2.1 Shenmai group In 60 cases, 41 males and 19 females; aged 28 to 74 years, median age 56 years. Specific disease is lung